We are live on ! Find out more
ATEX icon

Anterix

98 hedge funds and large institutions have $472M invested in Anterix in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 45 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more call options, than puts

Call options by funds: $5.8M | Put options by funds: $1.6M

30% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 10

3% more funds holding

Funds holding: 9598 (+3)

4% less capital invested

Capital invested by funds: $491M → $472M (-$19.1M)

2.45% less ownership

Funds ownership: 81.2%78.75% (-2.5%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

38% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 45

Holders
98
Holders Change
+3
Holders Change %
+3.16%
% of All Funds
1.55%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
13
Increased
28
Reduced
45
Closed
10
Calls
$5.8M
Puts
$1.6M
Net Calls
+$4.21M
Net Calls Change
+$4.37M

ATEX Hedge Fund Activity: Q3 2023 in Review

98 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Anterix (ATEX) for Q3 2023, worth a combined $472M — down 3.9% from $491M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ATEX positions and 10 closed out — a net gain of 3 holders — while 28 added to existing stakes and 45 trimmed.

The largest buyer was Jane Street, adding an estimated $2.42M. The largest seller was BlackRock, cutting an estimated $7.89M.

  • 98 institutional investors held Anterix (ATEX) as of Q3 2023, up from 95 in Q2 2023.
  • Funds reported $472M of Anterix stock for Q3 2023, down 3.9% quarter-over-quarter.
  • 13 funds opened new Anterix positions in Q3 2023 and 10 closed out, a net change of +3 holders.
  • The largest Anterix buyer in Q3 2023 was Jane Street, an estimated $2.42M added.
  • The largest Anterix seller in Q3 2023 was BlackRock, an estimated $7.89M sold.

Based on aggregated 13F filings for Q3 2023.